More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/GATA4 antibody

GATA4 antibody

GTX113194
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
DownloadDatasheet
Product group Antibodies
ReactivityHuman, Mouse
TargetGATA4
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    GATA4 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.21 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2626
  • Target name
    GATA4
  • Target description
    GATA binding protein 4
  • Target synonyms
    ASD2; GATA-binding factor 4; TACHD; TOF; transcription factor GATA-4; VSD1
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP43694
  • Protein Name
    Transcription factor GATA-4
  • Scientific Description
    This gene encodes a member of the GATA family of zinc-finger transcription factors. Members of this family recognize the GATA motif which is present in the promoters of many genes. This protein is thought to regulate genes involved in embryogenesis and in myocardial differentiation and function. Mutations in this gene have been associated with cardiac septal defects. [provided by RefSeq]
  • Reactivity
    Human, Mouse
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Role of FOXC1 in regulating APSCs self-renewal via STI-1/PrPC signaling. Lee YH et al., 2019, Theranostics
    Read more
  • Hydrogen sulfide enhances the effectiveness of mesenchymal stem cell therapy in rats with heart failure: In vitro preconditioning versus in vivo co-delivery. Abdelmonem M et al., 2019 Apr, Biomed Pharmacother
    Read more
  • A comparative study of the influence of two types of PHEMA stents on the differentiation of ASCs to myocardial cells. Lao S et al., 2017 Jul, Mol Med Rep
    Read more
  • Multiple gene variations contributed to congenital heart disease via GATA family transcriptional regulation. Qian Y et al., 2017 Apr 3, J Transl Med
    Read more
  • The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes. Wu VC et al., 2017 Jan 19, Sci Rep
    Read more